Audrey Michot, Van-Linh Le, Jean‐Michel Coindre, Valérie Velasco, Mohamed Soussi, Nouria Mesli, Antoîne Italiano, Maud Toulmonde, Axel Le Cesne, Sylvie Bonvalot, Lucile Vanhersecke, Charles Honoré, Carine Ngo, François Le Loarer, Olivier Saut, Amandine Crombé
The histological FNCLCC grade is the primary prognostic factor in soft-tissue sarcoma (STS) but fails to fully capture high risk patients. This study aimed to develop and validate a deep learning (DL) model to predict metastatic relapse-free survival (MFS) using digital hematoxylin and eosin-stained whole-slide images. A retrospective analysis was conducted on 308 STS patients from two cancer centers, divided into a training cohort (149 patients) and two independent validation cohorts (64 and 95 patients). Supervised multi-instance learning convolutional neural network models were trained on distinct tumor regions-center (C), periphery (P), and margins (R)-to optimize predictive performance. Univariable analysis showed DL models using tumor center (DL-C), periphery (DL-P), and their combination (DL-CP) were consistently associated with MFS across cohorts, while models incorporating margins (DL-R and DL-CPR) demonstrated less reliable associations. Multivariable Cox regression confirmed that high risk scores from DL models were independent predictors of MFS. The DL-CP model outperformed FNCLCC grading in prognostic accuracy, with c-indices ≥ 0.74 in validation cohorts. Adding tumor margin information did not improve predictions.DL models focusing on tumor center and periphery provide superior prognostic value in STS, offering a streamlined, effective approach for digital pathology-based risk stratification.